
Creyon Bio
Creyon is a drug development company enabling tissue specific delivery of RNA therapies designed to improve safety, efficacy, and patient experience in immunology, central nervous system (CNS), and neuromuscular disease.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJul 6, 2013 (13 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Companies like Creyon Bio
LLatus Bio$97M Series A · May 2026
SSleptaySeries A · Sep 2026
FFluoSphera$1.46M Seed · Jan 2026
SStarlight TherapeuticsSeed · Apr 2026
BBloom Science$12M Series A · Dec 2021
HHolobiomeSeed · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/creyon-bio (get a free API key).